Status:
COMPLETED
Risk Profile for Atrial Fibrillation
Lead Sponsor:
University Medical Center Groningen
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-80 years
Brief Summary
The objective of this study is to assess the risk profile in patients with atrial fibrillation, which represents the degree of changes (remodeling) in the atrial tissue and which can help to predict i...
Detailed Description
Atrial fibrillation is responsible for substantial morbidity and mortality.Identification of patients with AF that is difficult to treat may improve the outcome of rhythm control therapy. Left atrial ...
Eligibility Criteria
Inclusion
- Short-lasting symptomatic paroxysmal or persistent AF;
- Rhythm control strategy is preferred;
- No contra-indication for oral anticoagulation;
- Age \> 18 years;
- Written informed consent
Exclusion
- Total history of heart failure and/ or of severe valvular disease \> 3 years;
- Severe valvular disease;
- Acute coronary syndrome/ myocardial infarction/ percutaneous coronary intervention/ coronary artery bypass surgery within the past one month;
- Post-operative AF.
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
503 Patients enrolled
Trial Details
Trial ID
NCT01510197
Start Date
September 1 2011
End Date
March 1 2015
Last Update
July 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical center Groningen
Groningen, Provincie Groningen, Netherlands, 9700 RB